Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01499043
What this trial is testing

Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
Daiichi Sankyo 6
Testing effectiveness (Phase 2)Study completedNCT00284752
What this trial is testing

Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Kaiser Permanente 56
Testing effectiveness (Phase 2)Looking for participantsNCT07523529
What this trial is testing

Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors

Who this might be right for
Advanced UnresectableMetastatic
Beijing Biotech 72
Not applicableUnknownNCT03414437
What this trial is testing

Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303)

Who this might be right for
Prostate Cancer Metastatic
Carolina Research Professionals, LLC 31
Early research (Phase 1)Looking for participantsNCT06910657
What this trial is testing

IDOV-Immune for Advanced Solid Tumors

Who this might be right for
Colorectal CancerPancreatic CancerMelanoma+13 more
ViroMissile, Inc. 78
Not applicableStudy completedNCT01233557
What this trial is testing

Biomarkers of Bone Resorption in Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
University of Aberdeen 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03569241
What this trial is testing

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases

Who this might be right for
Prostate CancerProstate Cancer MetastaticMetastatic Cancer+1 more
University Hospital, Ghent 196
Not applicableLooking for participantsNCT07740239
What this trial is testing

A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial

Who this might be right for
Pelvic FractureProstate CancerLung Cancer+2 more
Tampere University Hospital 2,050
Early research (Phase 1)Study completedNCT03199586
What this trial is testing

Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies

Who this might be right for
Breast CancerPancreas CancerProstate Cancer+6 more
Novita Pharmaceuticals, Inc. 23
Not applicableUnknownNCT01168141
What this trial is testing

Window Study of ZD4054 in Metastatic Prostate Cancer

Who this might be right for
Prostate CancerMetastasis
The Christie NHS Foundation Trust 30
Not applicableStudy completedNCT01277562
What this trial is testing

Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer

Who this might be right for
Breast CancerProstate CancerOsteopenia+1 more
City of Hope Medical Center 56
Early research (Phase 1)Ended earlyNCT03043989
What this trial is testing

Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Early research (Phase 1)Temporarily pausedNCT01337518
What this trial is testing

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Enzon Pharmaceuticals, Inc. 150
Not applicableStudy completedNCT05131815
What this trial is testing

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

Who this might be right for
CancerCancer MetastaticNeoplasms+19 more
Cedars-Sinai Medical Center 8
Testing effectiveness (Phase 2)UnknownNCT04300673
What this trial is testing

Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerLymph Node Metastases
Radboud University Medical Center 20
Very early researchUnknownNCT06462495
What this trial is testing

Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Who this might be right for
Prostate CancerPET/CT
Anhui Provincial Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT00103428
What this trial is testing

Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys 69
Testing effectiveness (Phase 2)Ended earlyNCT05169684
What this trial is testing

BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Bristol-Myers Squibb 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06212583
What this trial is testing

High-Risk Metachronous Oligometastatic Prostate Cancer Trial

Who this might be right for
Prostate CancerOligometastatic Disease
University of Maryland, Baltimore 88
Not applicableUnknownNCT01769950
What this trial is testing

Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate Cancer

Who this might be right for
Prostate Cancer
Bangalore Institute of Oncology 120
Next Page